Jeff Evanson, Chief Commercial Officer at Outlook Therapeutics, Inc. (OTLK), sold 113,946 shares at $2.55 ($291K) on 2021-02-12, disclosed to the SEC on 2021-02-17.
Open-market sale of $291k OTLK by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.55 | 56,973 | $145K | 50.0% |
| 2 | $2.55 | 56,973 | $145K | 50.0% |
| Total | $2.55 avg | 113,946 | $291K | 100% |
| Filing → |
| OTLK | SELL | 2023-01-19 | $330K | — | Filing → |
| OTLK | BUY | 2021-12-06 | $47K | — | Filing → |
| OTLK | SELL | 2021-02-25 | $18K | — | Filing → |